Inhibiting connexin channels protects against cryopreservation-induced cell death in human blood vessels

Eur J Vasc Endovasc Surg. 2013 Apr;45(4):382-90. doi: 10.1016/j.ejvs.2012.12.012. Epub 2013 Jan 24.

Abstract

Objectives: Cryopreserved blood vessels are being increasingly employed in vascular reconstruction procedures but freezing/thawing is associated with significant cell death that may lead to graft failure. Vascular cells express connexin proteins that form gap junction channels and hemichannels. Gap junction channels directly connect the cytoplasm of adjacent cells and may facilitate the passage of cell death messengers leading to bystander cell death. Two hemichannels form a gap junction channel but these channels are also present as free non-connected hemichannels. Hemichannels are normally closed but may open under stressful conditions and thereby promote cell death. We here investigated whether blocking gap junctions and hemichannels could prevent cell death after cryopreservation.

Materials and methods: Inclusion of Gap27, a connexin channel inhibitory peptide, during cryopreservation and thawing of human saphenous veins and femoral arteries was evaluated by terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assays and histological examination.

Results: We report that Gap27 significantly reduces cell death in human femoral arteries and saphenous veins when present during cryopreservation/thawing. In particular, smooth muscle cell death was reduced by 73% in arteries and 71% in veins, while endothelial cell death was reduced by 32% in arteries and 51% in veins.

Conclusions: We conclude that inhibiting connexin channels during cryopreservation strongly promotes vascular cell viability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apoptosis / drug effects*
  • Cell Survival / drug effects
  • Chi-Square Distribution
  • Connexin 43 / antagonists & inhibitors
  • Connexin 43 / metabolism
  • Connexins / antagonists & inhibitors*
  • Connexins / metabolism
  • Connexins / pharmacology
  • Cryopreservation*
  • Cryoprotective Agents / pharmacology*
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology
  • Femoral Artery / drug effects*
  • Femoral Artery / metabolism
  • Femoral Artery / pathology
  • Femoral Artery / transplantation
  • Gap Junction alpha-4 Protein
  • Gap Junction alpha-5 Protein
  • Humans
  • In Situ Nick-End Labeling
  • Middle Aged
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism
  • Myocytes, Smooth Muscle / pathology
  • Oligopeptides
  • Saphenous Vein / drug effects*
  • Saphenous Vein / metabolism
  • Saphenous Vein / pathology
  • Saphenous Vein / transplantation

Substances

  • Connexin 43
  • Connexins
  • Cryoprotective Agents
  • Oligopeptides
  • gap 27 peptide